Menu

Element 2 - Supply of medicines, medical devices and poisons

2.2.1 - The T2C Pharmacy Medicines and Pharmacist Only Medicines Checklist Action 6.3 requires no direct access to Pharmacy Medicines by consumers. What does this mean?

Consumers must not be able to directly access Pharmacy Medicines. There needs to be a physical barrier which prevents consumers from directly selecting Pharmacy Medicines from the shelves. Examples of a physical barrier might be a counter, perspex barriers, portable stands, tape and poles similar to those used to assist people in forming a queue, or similar barriers.
This is a non-mandatory item.

Resources

2.2.2 - What is the T2C Supplying Pharmacy Medicines and Pharmacist Only Medicines Checklist?

The T2C Supplying Pharmacy Medicines and Pharmacist Only Medicines Checklist, is a checklist based on a standard template of requirements for the Delivery of Health Programs and Services. Most of these Health Programs and Services are implemented under Element 3 but as supplying Pharmacy Medicines and Pharmacist Only Medicines is a supply of medicines function, it has been included under Element 2. The checklist T2C is found in the templates section of the QCPP Requirements Manual. The checklist defines the actions which need to be implemented to meet each Program requirement, along with the guiding evidence requirements. The pharmacy should use this checklist to implement the actions.
 
Resources

2.2.3 - What is the T2D Supplying Pseudoephedrine Checklist?

The T2D Supplying Pseudoephedrine Checklist is a checklist based on a standard template of requirements for the Delivery of Health Programs and Services. Most of these Health Programs and Services are implemented under Element 3 but as supplying pseudoephedrine is a supply of medicines function, it has been included under Element 2. The checklist T2D is found in the templates section of the QCPP Requirements. The checklist defines the actions which need to be implemented to meet each program requirement, along with the guiding evidence requirements. The pharmacy should use this checklist to implement the actions. 

Resources

2.2.4 - Does a new staff member employed within 3 months of a pharmacy's QCPP assessment need to have a completed the Pharmacy Medicines and Pharmacist Only Medicines Certificate on the day of accreditation?

No. A new staff member, employed within 3 months of a pharmacy's QCPP assessment must have proof of enrolment in a Recognised Course in the supply of Pharmacy Medicines and Pharmacist Only Medicines at the time of accreditation.

Resources

2.2.5 - The T2D Supplying Pseudoephedrine Checklist Action 2 requires all staff to be trained in the sale of products containing pseudoephedrine. Does this include pharmacists?

Yes, all staff who are involved in the sale of pseudoephedrine are required to be trained in the sale of products containing pseudoephedrine. Qualifying as a pharmacist is recognised training in pseudoephedrine.  Pharmacists must meet the mandatory CPD requirements as defined in the Pharmacy Board of Australia's 'Pharmacy Continuing Professional Development Registration Standard'.

Resources

2.2.6 -The Supplying Pseudoephedrine Checklist has a program requirement number 3 which requires the pharmacy to have a list of products on sale within the pharmacy that contain pseudoephedrine. If a pharmacy has no staff, does it need this document?

Yes, this document is required by all pharmacies.

Resources

2.2.7 - The Supplying Pseudoephedrine Checklist has a program requirement number 6 which requires that all solid dose "pseudoephedrine plus antihistamine" and single-entity pseudoephedrine products including sustained release single ingredient products are placed out of reach and out of sight of customers. What does this mean?

All products that are required to be out of reach and out of sight of the customer must contain more than 30 mg of pseudoephedrine per dosage unit e.g. a single tablet. All other pseudoephedrine containing products (see T2D 6.2), for example liquid preparations or preparations containing less than 30 mg of pseudoephedrine per dosage unit must be placed out of reach, with no direct customer access.

Resources

2.2.8 -The T2D Supplying Pseudoephedrine Checklist Action 7.2 requires the pharmacy to have a procedure for the supply of Pseudoephedrine products. Can a pharmacy use their procedures for the sale of Pharmacy Medicines and Pharmacist Only Medicines to satisfy this requirement?

Yes, provided the procedure describes how the pharmacy's supplies pseudoephedrine containing products and addresses the key risks in the supply of pseudoephedrine. The 'evidence required at assessment' described in T2D Action 7.2, provide guidance on how this could be achieved.
 
Resources

2.2.9 - Is it sufficient that a pharmacy records the same information as recorded in the fields of ProjectSTOP in a paper based or manual system rather than an electronic system?

QCPP mandates the use of a recording system for the supply of products containing pseudoephedrine.  When determining the system the pharmacy uses, proprietors and managers must consider business needs and individual state requirements. These requirements differ between each state and territory, including the mandatory use of electronic and real-time monitoring in some jurisdictions.
 
Resources

2.2.10 - What is a Medical Device?

Medical devices are defined in section 3.3 of AS 85000, Quality Care Pharmacy Standard and also in the definitions section of the QCPP Knowledge Hub.

In practical terms, the definition would include items such as nebuliser pumps, asthma spacer devices, vaporisers, blood glucose monitors, blood pressure measuring devices etc. Although the additional information on this Element provides for this action being not applicable to some pharmacies, given the scope of the definition, it would be hard to imagine any community pharmacy that does not stock or order in for customers any such devices.

Resources

2.2.11 - What is defined as a Poison for the purposes of this action?

A poison, for the purposes of this action (and P2G), is defined as either -
  • A Schedule 7 Dangerous Poison as defined in The Standard for Uniform Scheduling of Medicines and Poisons, or
  • A chemical of national security concern (for example hydrogen peroxide).
If a pharmacy identifies that they do not handle Schedule 7 poisons or chemicals of national security concern, then this action will be deemed not applicable at QCPP assessment.

Resources

2.2.12 - What evidence is required at assessment for accredited training units completed to meet Refresher Training requirements?

As described in the Training Requirements for Pharmacy Medicines and Pharmacist Only Medicines, the evidence required to demonstrate the Refresher Training requirements is either a Statement of Attainment, or Transcript of Results issued by the RTO for a listed unit of competency, and a T15B Training Record. If there is a discrepancy between the date on the Statement of Attainment or Transcript of Results and the T15B Training Record, the earlier date will be accepted as evidence of completion.

Resources

2.2.13 - How do I record completion of accredited training modules on my Training Record?

The accredited module, including the module code, should be recorded on the Training Record on the date the training was completed. A copy of the Statement of Attainment/Transcript must also be kept on the training record. For purposes of QCPP assessment, the training will be accepted as having occurred on the date contained on the Statement of Attainment/Transcript or the date on the Training Record, whichever is earlier.

Resources

2.2.14 - What resources are available to support pharmacies in meeting the T2C Supplying Pharmacy Medicines and Pharmacist Only Medicines Checklist training requirements?

The following resources have been developed to assist pharmacies in understanding and meeting the requirements of T2C Supplying Pharmacy Medicines and Pharmacist Only Medicines Checklist Action 2.1.

Resources

2.2.15 - Do the supplying Pharmacy Medicines and Pharmacist Only Medicines training requirements apply to pharmacists who are qualified overseas, but are undertaking their bridging studies to be registered in Australia?

Overseas qualified pharmacists undertaking bridging training are deemed compliant. Bridging training will cover the legal background of non-prescription medicine scheduling in Australia as part of the entrance to their program.

Resources

2.2.16 - Do the supplying Pharmacy Medicines and Pharmacist Only Medicines training requirements apply to staff members who are also pharmacy students?

Australian pharmacy students who have successfully completed their first year of pharmacy studies, including those studying a Masters in Pharmacy, and are actively enrolled (i.e. not deferred) are deemed compliant with the Pharmacy Medicines and Pharmacist Only Medicines training requirements.
The staff member (student) will need to provide evidence that he or she has successfully completed the first year of the pharmacy degree through the provision of an academic statement or semester one and two results from the university and confirmation they are actively enrolled and not deferred from study.

Resources

2.2.17 - Do the supplying Pharmacy Medicines and Pharmacist Only Medicines and training requirements apply to pharmacy assistants with overseas training?

Yes. The training requirements apply to a pharmacy assistant who has completed training overseas and is now working in Australia. The rationale for this ruling is that the Australian regulatory and professional framework for supplying non-prescription medicines would not have been covered in overseas training. Resources

2.2.18 - How do QCPP Assessors determine who the supplying Pharmacy Medicines and Pharmacist Only Medicines training requirements apply to?

Yes. Assessors can determine if a staff member is involved in the supply of Pharmacy Medicines and/or Pharmacist Only Medicines by:
  • Reviewing the position description and the staff roster
  • Asking staff within the pharmacy who is involved in the supply of Pharmacy Medicines and/or Pharmacist Only Medicines
  • Observation within the pharmacy on the day of assessment, and request to view training records of employees involved in the direct sale of Pharmacy Medicines and/or Pharmacy Only Medicines
Resources

2.2.19 - Can staff training conducted via Skype meet the requirements of 'in-pharmacy' Refresher Training?

Yes. Refresher Training through electronic delivery methods such as Skype or Webinars would be appropriate for 'in-pharmacy' training as long as it is delivered by a pharmacist or senior staff member employed within the pharmacy Resources

2.2.20 - Can training delivered by a banner group be considered 'in-pharmacy' refresher training?

No. In-Pharmacy training must be delivered by a pharmacist or senior staff member employed within the pharmacy. Training delivered by a pharmacy group such as online eLearning modules and evening training sessions must be approved by QCPP to be recognised as Approved Refresher training at QCPP assessment. Training developed by a banner group which is delivered by someone employed within the relevant pharmacy may be deemed in-pharmacy training. Resources

2.2.21 - How are remedials treated when a staff member has not completed the minimum 3 hours per year Refresher Training requirement?

If a staff member has not completed the minimum 3 hours Refresher Training for each year, the Assessor will raise a remedial action. The remedial action will be closed out when the pharmacy provides the Assessor with evidence the staff member has completed 3 hours Refresher Training for the last year. Resources

2.2.22 - Are all staff required to complete Interprofessional Collaboration training?

No. Only those staff involved in Interprofessional Collaboration within the pharmacy need to be familiar with the delivery of this service. A Training Record or completed Induction Checklist should indicate relevant staff have read and understood their pharmacy's policy on Interprofessional Collaboration. Resources

2.2.23 - What evidence is required to meet the T2C Supplying Pharmacy Medicines and Pharmacist Only Medicines Checklist requirements for initial staff training via a Recognised Course?

The evidence required is outlined in the Training Requirements for Pharmacy Medicines and Pharmacist Only Medicines. The assessment methodology used for this requirement is as follows:

  • During an initial QCPP assessment, the Assessor will require the certificates of all staff requiring initial training and their T15B Training Record.
  • During subsequent QCPP assessments, the Assessor will need to sight the initial training certificate and T15B training record for all new employees or employees who now require (due to a change in position description or duties) completion of initial training, since the pharmacy's last QCPP assessment (employed in the last 2.5 years)

Resources

2.2.24 - What evidence is required to meet the T2CSupplying Pharmacy Medicines and Pharmacist Only Medicines Checklist requirements for ongoing Refresher Training?

The evidence required is outlined in the Training Requirements for Pharmacy Medicines and Pharmacist Only Medicines. During a QCPP assessment, the Assessor will select a sample of 5 pharmacy assistant T15B Training Records and/or personnel files to ensure annual Refresher Training requirements have been met.
To assist pharmacies in meeting this requirement, it is recommended to have a list of employees and the details of their training ready on the day of assessment. Please note the Assessor will select 5 records to be reviewed.

Resources

2.2.25 - What is a chemical of security concern?

A chemical of security concern is a chemical which has the potential to be diverted from its lawful use to use for other purpose, including terrorist related activity. For community pharmacy, hydrogen peroxide is the most common chemical of security concern. More information for pharmacies regarding chemicals of security concern can be found below. Resources

2.2.26 - Is there a minimum length of time for training sessions, when meeting the requirements of Refresher Training?

No. To assist pharmacies in delivering training to meet the needs of their employees, there is no minimum duration for Refresher Training per session. The training must however meet the requirements, as outlined in the training requirements brochure located on the QCPP website. Resources

2.2.27 - If a pharmacy never supplies pseudoephedrine products, does it need to comply with T2D Supplying Pseudoephedrine Checklist?

Yes. All QCPP accredited pharmacies must meet the requirements of T2D Supplying Pseudoephedrine Checklist. If a pharmacy never supplies pseudoephedrine products, the following is required to demonstrate compliance with the checklist:
  • A P2E Supplying Pseudoephedrine Policy stating that it is the pharmacy’s policy not to stock or supply pseudoephedrine, and how customer requests for pseudoephedrine containing products would be handled (Action 7.1).
  • Training Records that demonstrate all staff are aware of this policy and how to respond to requests for pseudoephedrine containing products (Action 2.1).

By not stocking or advertising any pseudoephedrine containing products, the pharmacy would comply with other actions (Actions 6.1, 6.2, 6.3 and 6.4)

2.2.28 - Do Pharmacist Only Medicines need to be stored out of sight from customers?

There are no specific requirements within QCPP relating to whether Pharmacist Only Medicines should be stored out of sight of customers, with the exception of some pseudoephedrine containing products.
T2D Actions 6.1 (Supplying Pseudoephedrine Checklist) requires specific pseudoephedrine containing products out of sight of customers. This includes:

  • Single-entity pseudoephedrine
  • Pseudoephedrine with antihistamine

Pharmacies are reminded to ensure that they continue to meet legislative and professional requirements when storing and displaying medicines, including Pharmacist Only Medicines.
 

2.2.29 – Where can I access the ‘Standards for Provision of Pharmacy Medicines and Pharmacist Only Medicines in Community Pharmacy’ referred to on the QCPP Maintenance Checklist and T2C: Pharmacy Medicines and Pharmacist Only Medicines Checklist?

The ‘Standards for Provision of Pharmacy Medicines and Pharmacist Only Medicines in Community Pharmacy’ has been retired, with the standards now incorporated into the PSA Professional Practice Standards Version 5. Pharmacies will not be expected to have access to the retired standard on the day of QCPP assessment. 

 Resources

2.2.30 – T2C: Pharmacy Medicines and Pharmacist Only Medicines Checklist, Action 7.1 and 7.2, require proof the pharmacy’s procedures and protocols include steps contained in procedures and protocols published in the ‘Standards for the Provision of Pharmacy Medicines and Pharmacist Only Medicines in Community Pharmacy’. How does the pharmacy meet these requirements now that the standard has been retired?

In order to meet the requirements of Action 7.1 and 7.2, the pharmacy must ensure relevant staff have been appropriately trained in, and are following, a recognised S2/S3 supply protocol (i.e. Ask, Assess, Advise, CARER or What-Stop-Go). On the day of assessment, the assessor will check this requirement by observation, role-play or questions directed to staff.

The pharmacy must also maintain and follow a procedure for responding to consumers who require access to the pharmacist, ensuring factors such as how consumers will be triaged during busy periods have been considered.

Resources

2.2.31 - What is acceptable evidence for S2/S3 initial training?

On completion of S2/S3 initial training the Registered Training Organisation (RTO) can provide you with the following documents as evidence of satisfactory achievement of the course:

1. Completion certificate
2. Statement of attainment

These documents will require:

  • Graduate name
  • Full title of accredited units
  • Date of issue
  • Issuing organisation details

An email confirmation f completion is not an acceptable form of evidence.

2.2.32 – Can I use my USI transcript as evidence for S2/S3 initial training?

Yes, this is an acceptable form of evidence.

Every graduate has a Unique Student Identifier (USI) which allows access to a user portal on www.usi.gov.au. This portal will have a printable transcript of all nationally recognised training completed from 2015. Please note that the RTO provides submissions on either a quarterly or annual basis, which means recently completed courses may not appear on the transcript.

Element 2 and 3 Professional Services Checklists – What version of the “approved guidelines” does the pharmacy need to maintain access to?

The pharmacy is required to maintain access to the current version of all “approved guidelines”, similarly to being required to have access to the current edition of reference texts as per The Pharmacy Board of Australia guidelines.

2.3.1 - Is a pharmacy permitted to deliver cold chain medicines (e.g. insulin) through their Distance Supply service?

Yes. A pharmacy may deliver cold chain medicines. However, it is the pharmacy's responsibility to ensure cold chain storage requirements are being maintained throughout the delivery process and relevant procedures are followed.

 Resources

2.3.2 - Is a pharmacy required to promote or advertise their Distance Supply service?

A pharmacy must have promotional information about its Distance Supply service. A simple brochure supplied to customers who enquire about the service would be sufficient. There is no requirement to advertise the service. Resources

2.5.1 - What is the Distance Supply Checklist?

The T2A Distance Supply Checklist is a checklist based on a standard template of requirements for the Delivery of Health Programs and Services. Most of these Health Programs and Services are implemented under Element 3 but as Distance Supply is considered to be a dispensing function, it has been included under Element 2. The checklist T2A is found in the templates section of the QCPP Requirements Manual. The checklist defines the actions which need to be implemented to meet each Program requirement, along with the guiding evidence requirements. The pharmacy should use this checklist to implement the actions and the Assessor will use the checklist to guide evidence requirements. Resources

2.5.2 - If a pharmacy provides a distance supply service but does not provide Internet pharmacy, how will it be scored for the actions on Checklist T2A that refer to an Internet Pharmacy?

If the pharmacy does not provide an Internet Pharmacy service, any actions relating to Internet Pharmacy will be deemed not applicable (as per Program & Assessment Rule 18) and not be assessed. Resources

2.5.3 - When is an individual pharmacy considered to be offering internet supply services and assessable under the  T2A Distance Supply Checklist?

Within the current QCPP requirements, a pharmacy will be assessed against T2A Distance Supply Checklist (including internet pharmacy requirements) when the pharmacy has direct linkage to, and control of, the information within the website where goods are sold.

In the event the website information is held and managed by the Head Office, this would not be assessed as internet pharmacy. Depending on the nature of the service(s) provided, the pharmacy may or may not need to be assessed against other aspects of T2A Distance Supply Checklist.
 
Resources

2.6.1 - What is Simple Compounding?

Simple Compounding is the usual extemporaneous dispensing that takes place in a community pharmacy. (e.g. preparing creams, ointments, mixtures). The term Simple Compounding is used to distinguish this type of compounding from the more complex compounding processes which have been developed by specialist groups such as Professional Compounding Chemists of Australia (PCCA). Resources

2.6.2 - The T2B Compounding Worksheet contains mandatory fields. Does this mean the pharmacy must complete a Compounding Worksheet for every compounded item it dispenses?

The Evidence Required at Assessment for this action requires the pharmacy to have a Simple Compounding procedure. Action 6 in the sample procedure P2C requires a compounding worksheet to be developed. Action 6 however, is not a mandatory action. Therefore, the use of a compounding worksheet is not mandatory. If the pharmacy did want to use a compounding worksheet/notebook, its procedure should reflect this and the compounding worksheet they use must contain the mandatory fields. Resources

2.7.1 - If a pharmacy does not normally count out; and re-package cytotoxic drug products, does it need to have a procedure and any associated equipment?

Whilst a pharmacy may not normally re-package cytotoxic drug products, it is to have a procedure in place in case the need arises in response to, for example, a specific Doctor request. The pharmacy would not be expected to have the separate counting equipment and protective clothing on hand, as the chances of having to re-package cytotoxic drug products are remote, and the required equipment can be quickly obtained. Resources

2.7.2 - If a robotic dispensing system is in place, what are the Cytotoxic labelling requirements?

To ensure compliance with the Storing and Repackaging Cytotoxic Drug Products Procedure P2D, pharmacies have a number of options available. The cytotoxic labelling requirements will depend on the type of robotic dispensing system in place. The option to label all cytotoxic products remains. Alternatively, pharmacies using fixed channel systems can label the front and back of channels used to store cytotoxic medicines, and pharmacies using randomised chaotic systems can place cytotoxic medicines in specifically designed plastic 'clips' or 'holders' labelled cytotoxic. Pharmacies can still opt to store cytotoxic medicines all together outside of the robotic dispensing system, in a labelled location within the dispensary.
 
Resources

2.9.1 - Can the pharmacy just use the sample policy P2H Clinical Intervention Policy provided in the QCPP manual?

The document P2H Clinical Intervention Policy is not a sample policy. It is a document that provides issues for the pharmacy to consider when formulating its own policy. P2H as written in the manual would not be acceptable to an Assessor as a policy document.

Resources

2.9.2 - Will Clinical Intervention records be viewed on the day of assessment?

Yes. A sample of records may be viewed to ensure consistency with the recording requirements. Assessors may elect to do this via visual review of the electronic data within systems such as GuildCare, or through viewing paper based reports.

Resources

2.9.3 - Should Clinical Interventions for non-prescription medicines be recorded?

Yes. Clinical Interventions involving non-prescription medicines should be recorded using the pharmacy's documentation system and classification system. If exact customer details are not known, the documentation system should allow a unique identifier (for example alphanumeric value) to be recorded for each intervention).

Resources

2.9.4 - Is the use of salutations such as 'Mr' or "Mrs", considered a record of gender when recording a clinical intervention?

Recording customer details such as gender is a mandatory requirement of the T2G Clinical Interventions Checklist. Therefore, the pharmacy must use a system to be able to identify the gender of a customer on the clinical intervention record.
How the pharmacy elects to record gender is a decision for the pharmacy to make. However, the pharmacy must ensure there is a consistent distinguisher of gender within the clinical intervention recording system.

Resources

2.9.5 - What does ‘outcome’ mean when recording a clinical intervention?

The word outcome is defined as - the way a thing turns out; a consequence.
The requirement is to record the actual outcome (if known), or the anticipated outcome (if unknown).
For example, If a pharmacist intervenes to recommend commencing preventative laxative therapy (R8) when a patient commences taking slow release oxycodone (U3), the outcome could be anticipated to be 'reduced risk of constipation'. It is understood that in some instances the outcome may be the same as recording the recommendation classification code.

Resources

2.9.6 - Can a script number be used as a unique identifier when recording a clinical intervention?

No. A unique patient identifier (such as an alphanumeric value) should only be used in situations where the patient name is not known, such as clinical interventions involving non-prescription medicines.
If the clinical intervention relates to a prescription, the patient name will be available and should be used within the clinical intervention recording system.

Resources

2.10.1 - Can the pharmacy just use the sample P2I Inter-professional Collaboration Policy provided in the QCPP manual?

The P2I Inter-professional Collaboration Policy is not a sample policy. It is a document that provides issues for the pharmacy to consider when formulating its own policy. P2I as written in the manual would not be acceptable to an Assessor as a policy document.

Resources

2.11.1 - The P2J Return of Unwanted Medicines procedure requires the pharmacy to have a RUM approved container. Is the RUM bin provided by the Return of Unwanted Medicines project the only bin consistent with QCPP requirements?

No. There are other companies that provide suitable containers for the return of unwanted medicines. It is important that the container has the features required such as a tamper proof seal and a lid that will firmly attach. Also, how the company disposes of the unwanted medicines is important. 

Resources

2.11.2 - What does the pharmacy need to do if a RUM bin cannot be kept in the dispensary?

If the size of the RUM bin prevents it from being kept in the dispensary, it needs to be kept in an area out of public access and under the control of the pharmacist in the professional service area. Pharmacies are reminded to ensure their legal obligations for the storage of scheduled medicines are met.

Resources

T2E - Who are considered health professionals in the context of inter-professional collaboration?

All health professionals, as defined by the Australian Health Professional Registering Authority (AHPRA) and/or the current Medicare Benefits Schedule (MBS). The list of recognised health professionals include:
  • Chiropractors
  • Dental Practitioners
  • Medical Practitioners
  • Nursing and midwifery
  • Optometrists
  • Osteopaths
  • Physiotherapists
  • Podiatrists
  • Psychologists
  • Aboriginal and Torres Strait Islander practitioners
  • Chinese medicine practitioners
  • Medical radiation practitioners
  • Occupational therapists
  • Diabetes educators
  • Speech pathologists
  • Dieticians
  • Exercise physiologists
Resources

T2G - How should a pharmacy record a clinical intervention related to OTC medicines?

Clinical Interventions checklist T2G action 8.1c requires the recording system to include consumer details comprising of a patient identifier [e.g. name or number], age range and gender and relevant consumer history.  The recording of clinical interventions associated with Pharmacy Medicines or Pharmacist Only Medicines is encouraged and note the recording system only requires a unique consumer identifier. This maybe at the discretion of the pharmacy and may include an alpha numeric coding system (for example OTC1, OTC2, OTC3).

Resources

P2K - Do staged supply medications need to be supplied in child resistant, tamper evident containers?

No. The P2K Staged Supply Procedure stipulates the medicine must be supplied in a container. It does not specifically require the medicine to be supplied in a child resistant, tamper evident container.

Resources

P2K - Are all staff required to complete staged supply training?

No. Only those staff involved in providing staged supply within the pharmacy need to be familiar with the delivery of this service. A training record should indicate relevant staff have read and understood their pharmacy's procedure on staged supply.

Resources

© The Pharmacy Guild of Australia | Disclaimer | Privacy Policy | Contact Us
0123movies